Clinical Trial Update: TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating traditional Chinese medicine as an adjuvant treatment for Mycobacterium abscessus pulmonary disease, with recruitment ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Pulmonary Disease

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Mycobacterium Abscessus Pulmonary Disease | Phase 2 | Status: RECRUITING